Earnings History Data for Veru Inc. (VERU) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Veru Inc.

Veru Inc. engages in the development, manufacture and marketing of consumer health care products. It focuses on producing FC2 female condom which provides dual protection against unintended pregnancy and sexually transmitted infections. Veru Inc., formerly known as The Female Health Company, is headquartered in Miami, FL.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
08-08-2024	PM		VERU	Veru Inc.	118.73	-0.07	-0.06	-0.13	Veru GAAP EPS of -$0.07, revenue of $4M [8/8/2024 6:47 AM]	0.8064	0.04 (4.86%)	0.82	0.05 (6.63%)	0.36 - 1.92	497,721	600,000	17,419
Veru Q2 2024 Earnings Preview [8/7/2024 12:27 PM] Veru GAAP EPS of -$0.07, revenue of $4M [8/8/2024 6:47 AM]
08-05-2024	PM		VERU	Veru Inc.	240.07	-0.07	-0.06	-0.44	Veru GAAP EPS of -$0.07 misses by $0.01, revenue of $4.14B beats by $4.14B [5/8/2024 6:33 AM]	1.43	-0.20 (-12.27%)	1.43	0.0 (0.00%)	0.36 - 1.92	3,203,820	2,530,000	939
Veru GAAP EPS of -$0.07 misses by $0.01, revenue of $4.14M [5/8/2024 6:33 AM] Veru Q2 2024 Earnings Preview [5/7/2024 12:06 PM]
08-02-2024	PM		VERU	Veru Inc.	64.51	N/A	-0.14	-0.46	Veru reports Q1 results [2/8/2024 6:31 AM]	0.4123	-0.03 (-6.30%)	0.43	-0.01 (-2.61%)	0.36 - 5.38	1,323,165	1,930,000	160,476
Veru Q1 2024 Earnings Preview [2/7/2024 12:05 PM] Veru reports Q1 results [2/8/2024 6:31 AM]
10-08-2023	PM		VERU	Veru Inc.	97.27	-0.13	-0.20	-0.28	Veru GAAP EPS of $0.07 beats by $0.27, revenue of $3.34M misses by $6.88M [8/10/2023 6:34 AM]	1.08	0.0 (0.00%)	1.09	0.01 (0.94%)	0.93 - 24.55	939,264	900,000	21,957
Veru Q2 2023 Earnings Preview [8/9/2023 11:42 AM] Veru GAAP EPS of $0.07 beats by $0.27, revenue of $3.34M misses by $6.88M [8/10/2023 6:34 AM]
11-05-2023	PM	6:30 AM ET (May 11)	VERU	Veru Inc.	120.13	-0.44	-0.33	-0.18	Veru GAAP EPS of -$0.48 misses by $0.15, revenue of $6.6M beats by $2.27M [5/11/2023 6:34 AM]	1.22	-0.27 (-18.09%)	1.51	0.02 (1.34%)	0.93 - 24.55	3,311,432	1,670,000	91,201
Veru Q2 2023 Earnings Preview [5/10/2023 12:14 PM] Veru GAAP EPS of -$0.48 misses by $0.15, revenue of $6.6M beats by $2.27M [5/11/2023 6:34 AM]
09-02-2023	PM	6:30 AM ET (Feb 9)	VERU	Veru Inc.	436.17	-0.46	-0.38	-0.08	Veru GAAP EPS of -$0.46 misses by $0.08, revenue of $2.51M misses by $2.56M [2/9/2023 6:31 AM]	3.98	-1.15 (-22.51%)	4.47	-0.66 (-12.87%)	3.88 - 24.55	5,654,236	1,940,000	594,890
Veru Q1 2023 Earnings Preview [2/8/2023 11:43 AM] Veru GAAP EPS of -$0.46 misses by $0.08, revenue of $2.51M misses by $2.56M [2/9/2023 6:31 AM] Veru hits 52-week low after massive Q1 revenue miss [2/9/2023 10:45 AM]
05-12-2022	PM	6:30 AM ET (Dec 5)	VERU	Veru Inc.	439.20	-0.51	-0.29	-0.05	Veru GAAP EPS of -$0.51 misses by $0.21, revenue of $2.59M misses by $8.96M [12/5/2022 6:33 AM]	5.83	0.33 (5.91%)	5.43	-0.07 (-1.27%)	4.34 - 24.55	8,933,525	2,950,000	285,774
Veru GAAP EPS of -$0.51 misses by $0.21, revenue of $2.59M misses by $8.96M [12/5/2022 6:33 AM] Veru jumps 11% as Q4 update reignites hopes for COVID therapy [12/5/2022 11:07 AM] Hot Stocks: VERU rises after quarterly update; EH extends momentum; UAL upgrade; SNOW drops [12/5/2022 1:18 PM] Is Veru a Buy? [Dec-02-22 09:00AM] Veru Reports Fiscal 2022 Fourth Quarter and Full Year Financial Results [Dec-05-22 06:30AM] Veru Inc. (VERU) Reports Q4 Loss, Lags Revenue Estimates [Dec-05-22 07:45AM]
11-08-2022	PM	6:30 AM ET (Aug 11)	VERU	Veru Inc.	1,130	-0.28	-0.18	-0.03	Veru GAAP EPS of -$0.28 misses by $0.12, revenue of $9.6M misses by $7.48M [8/11/2022 6:35 AM]	15.99	4.22 (35.85%)	14.16	2.39 (20.31%)	4.34 - 18.40	54,257,630	4,870,000	4,026,834
Veru Q3 2022 Earnings Preview [8/10/2022 1:41 PM] Veru GAAP EPS of -$0.28 misses by $0.12, revenue of $9.6M misses by $7.48M [8/11/2022 6:35 AM] Veru stock gains ~20% premarket as potential COVID approvals overshadow Q2 results miss [8/11/2022 9:24 AM] Got $5,000? These 2 Stocks Are Crushing the Market This Year [Aug-10-22 10:45AM]
12-05-2022	PM	6:30 AM ET (May 12)	VERU	Veru Inc.	623.59	-0.18	-0.16	-0.04	Veru GAAP EPS of -$0.18 misses by $0.06, revenue of $13.03M misses by $2.23M [5/12/2022 6:32 AM]	9.03	0.87 (10.66%)	8.92	-0.11 (-1.22%)	4.34 - 17.50	13,172,014	13,330,000	2,838
Veru Q2 2022 Earnings Preview [5/11/2022 1:20 PM] Veru stock rises as FDA agrees data enough to file EUA for COVID drug sabizabulin [5/11/2022 7:41 AM] Veru GAAP EPS of -$0.18 misses by $0.06, revenue of $13.03M misses by $2.23M [5/12/2022 6:32 AM] Why Veru Shares Are Soaring Today Premarket [May-11-22 08:23AM] Veru stock soars after FDA agrees COVID-19 treatment can be submitted for EUA application [May-11-22 06:40AM] FDA States that Veru Should Submit Request for Emergency Use Authorization (EUA) Based on Positive Efficacy and Safety Data from the Phase 3 Clinical Study of Sabizabulin in Hospitalized COVID-19 Patients [May-11-22 06:30AM] Veru Reports Second Quarter Fiscal 2022 Results and Progress of Sabizabulin for COVID-19 Toward a Request for Emergency Use Authorization [May-12-22 06:30AM] Veru Inc. (VERU) Reports Q2 Loss, Misses Revenue Estimates [May-12-22 07:45AM]
09-02-2022	PM	6:30 AM ET (Feb 9)	VERU	Veru Inc.	426.66	-0.08	-0.11	-0.02	Veru GAAP EPS of -$0.08 beats by $0.02, revenue of $14.14M misses by $3.16M [2/9/2022 6:36 AM]	6.01	0.36 (6.28%)	5.62	-0.03 (-0.53%)	4.37 - 24.57	1,495,028	1,150,000	23,413
Veru FQ1 2022 Earnings Preview [2/8/2022 1:16 PM] Veru GAAP EPS of -$0.08 beats by $0.02, revenue of $14.14M misses by $3.16M [2/9/2022 6:36 AM] Can Veru Inc. (VERU) Climb 344% to Reach the Level Wall Street Analysts Expect? [Feb-08-22 10:00AM] Veru Reports First Quarter Fiscal 2022 Results as US FC2 Prescription Net Revenues Climb 27% [Feb-09-22 06:30AM] Veru Inc. (VERU) Reports Q1 Loss, Misses Revenue Estimates [Feb-09-22 07:45AM]
02-12-2021	PM	6:30 AM ET (Dec 2)	VERU	Veru Inc.	598.90	-0.05	-0.08	-0.01	Veru EPS beats by $0.04, misses on revenue [12/2/2021 6:36 AM]	6.93	0.03 (0.36%)	6.90	-0.01 (-0.14%)	2.95 - 24.57	1,507,392	960,000	13,403
Veru Q4 2021 Earnings Preview [12/1/2021 11:30 AM] Veru EPS beats by $0.04, misses on revenue [12/2/2021 6:36 AM] Veru Reports Record Fiscal 2021 Full-Year Financial Results [Dec-02-21 06:30AM] Veru Inc. (VERU) Reports Q4 Loss, Misses Revenue Estimates [Dec-02-21 10:20AM]
12-08-2021	PM	6:30 AM ET (Aug 12)	VERU	Veru Inc.	565.75	-0.03	-0.06	-0.05	Veru EPS beats by $0.03, beats on revenue [8/12/2021 6:33 AM]	7.44	0.48 (6.90%)	7.44	0.0 (0.00%)	2.30 - 24.57	1,212,901	500,000	23,128
Veru EPS beats by $0.03, beats on revenue [8/12/2021 6:33 AM] Veru +7% after earnings smasher on record revenue [8/12/2021 11:16 AM] Veru Sets Another Quarterly Record in Both Net Revenues and in Gross Profit for Fiscal 2021 Third Quarter [Aug-12-21 06:30AM] Veru Inc. (VERU) Reports Q3 Loss, Tops Revenue Estimates [Aug-12-21 07:55AM]
12-05-2021	PM	6:30 AM ET (May 12)	VERU	Veru Inc.	579.11	-0.04	-0.03	-0.01	Veru pops 5% after fiscal Q2 results; FC2 prescription revenues climbs 48% [5/12/2021 7:15 AM]	7.24	-0.25 (-3.34%)	7.24	0.0 (0.00%)	2.30 - 24.57	2,006,674	3,930,000	759
Veru pops 5% after fiscal Q2 results; FC2 prescription revenues climbs 48% [5/12/2021 7:15 AM] Veru EPS misses by $0.01, misses on revenue [5/12/2021 6:34 AM] Veru, Inc. to Host Earnings Call [May-12-21 06:15AM] Veru Reports Strong Second-Quarter Financial Results Based on Record High FC2 Prescription Revenues [May-12-21 06:30AM] Veru Inc. (VERU) Reports Q2 Loss, Misses Revenue Estimates [May-12-21 10:31AM]
10-02-2021	PM	6:30 AM ET (Feb 10)	VERU	Veru Inc.	1,000.00	-0.02	-0.04	-0.05	Veru EPS in-line, beats on revenue [2/10/2021 6:31 AM]	19.32	0.05 (0.26%)	22.04	2.77 (14.37%)	2.30 - 24.57	11,679,459	11,711,633	753,861
Veru EPS in-line, beats on revenue [2/10/2021 6:31 AM] Female Health Company The (VERU) Reports Q1 Loss, Tops Revenue Estimates [Feb-10-21 07:45AM] Veru Sets Another Quarterly Record in Both Net Revenues and in Gross Profit for Fiscal 2021 First Quarter [Feb-10-21 06:30AM] Veru, Inc. to Host Earnings Call [Feb-10-21 06:15AM] Why Veru Stock Surged Today [Feb-09-21 07:01PM] Veru Leaps on Progress With COVID-19 Treatment Trial [Feb-09-21 10:23AM] Biotech Veru Surges Higher, Here's My Buy Strategy [Feb-09-21 02:58AM]
09-12-2020	PM	6:30 AM ET (Dec 9)	VERU	Veru Inc.	234.04	-0.01	-0.05	-0.05	Veru EPS misses by $0.13, beats on revenue [12/9/2020 6:33 AM]	3.86	0.62 (18.95%)	3.27	0.02 (0.77%)	2.10 - 4.74	4,510,251	318,396	98,893
Veru EPS misses by $0.13, beats on revenue [12/9/2020 6:33 AM] Veru in-licenses late-stage androgen receptor targeted therapy for breast cancer [12/9/2020 7:39 AM] Recap: Veru Q4 Earnings [Dec-09-20 07:06AM] Veru Expands Oncology Drug Pipeline; Exclusively Licenses Phase 3 Clinical Stage Targeted Therapy for Endocrine Resistant Metastatic Breast Cancer [Dec-09-20 06:55AM] Veru, Inc. to Host Earnings Call [Dec-09-20 06:15AM] Preview: Veru's Earnings [Dec-08-20 10:05AM]
13-08-2020	PM	6:30 AM ET (Aug 13)	VERU	Veru Inc.	212.39	-0.05	-0.03	-0.04	Veru EPS misses by $0.02, misses on revenue [8/13/2020 6:32 AM]	2.81	-0.22 (-7.26%)	2.98	-0.05 (-1.65%)	1.67 - 4.74	740,668	764,607	11,493

13-05-2020	PM	6:30 AM ET (May 13)	VERU	Veru Inc.	245.13	-0.01	-0.04	-0.06	Veru EPS beats by $0.02, misses on revenue [5/13/2020 6:31 AM]	3.97	0.44 (12.46%)	3.77	-0.20 (-5.04%)	1.50 - 4.74	1,881,462	516,682	2,297